SLGL (Sol-Gel Technologies) Retained Earnings: $-240.74 Mil (As of Mar. 2026)


SLGL Sol-Gel Technologies Ltd SLGL
55 GF Score
Price $74.50
GF Value $65.60
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Retained Earnings?

Sol-Gel Technologies SLGL +3.58% 55 Retained Earnings is $-240.74 Mil as of Mar. 2026. GuruFocus rates SLGL with a GF Score™ of 55/100 and a GF Value™ of $65.60 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Sol-Gel Technologies's retained earnings for the quarter that ended in Mar. 2026 was $-240.74 Mil.

Sol-Gel Technologies's quarterly retained earnings declined from Sep. 2025 ($-234.02 Mil) to Dec. 2025 ($-237.01 Mil) and declined from Dec. 2025 ($-237.01 Mil) to Mar. 2026 ($-240.74 Mil).

Sol-Gel Technologies's annual retained earnings declined from Dec. 2023 ($-220.30 Mil) to Dec. 2024 ($-230.88 Mil) and declined from Dec. 2024 ($-230.88 Mil) to Dec. 2025 ($-237.01 Mil).


Sol-Gel Technologies  (NAS:SLGL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Sol-Gel Technologies Retained Earnings Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies Retained Earnings Chart

Sol-Gel Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -178.14 -193.07 -220.30 -230.88 -237.01

Sol-Gel Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -239.69 -228.08 -234.02 -237.01 -240.74
SLGL
55GF Score
Sol-Gel Technologies Ltd SLGL
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sol-Gel Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-240.74 Mil mean?
Sol-Gel Technologies (SLGL) has a Retained Earnings of $-240.74 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Sol-Gel Technologies and its competitors.
Is Sol-Gel Technologies' Retained Earnings too high?
Sol-Gel Technologies' current Retained Earnings is $-240.74 Mil. Overall, Sol-Gel Technologies has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' Retained Earnings compare to AVXL and FATE?
Sol-Gel Technologies' Retained Earnings of $-240.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Sol-Gel Technologies and its competitors. Sol-Gel Technologies's current Retained Earnings is $-240.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.60, compared to a current price of $74.50 — trading 13.6% above its estimated fair value. The current Retained Earnings is $-240.74 Mil. Sol-Gel Technologies' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current Retained Earnings is $-240.74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $74.50 is trading 13.6% above its estimated GF Value™ of $65.60. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

  • Retained Earnings: $-240.74 Mil
  • GF Value™: $65.60 vs. price of $74.50 (13.6% above fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
55GF Score

Get the complete analysis for SLGL

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$74.50
Price
$65.60
GF Value